We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Benchmark Holdings Plc | LSE:BMK | London | Ordinary Share | GB00BGHPT808 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 0.58% | 43.50 | 43.00 | 43.50 | 42.90 | 42.40 | 42.90 | 334,274 | 16:35:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 169.74M | -23.15M | -0.0313 | -13.71 | 317.18M |
TIDMBMK
RNS Number : 9324M
Benchmark Holdings PLC
14 January 2019
14 January 2019
Benchmark Holdings plc
("Benchmark" or the "Company")
Notice of Preliminary Results
Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, will announce its preliminary results for the year ended 30 September 2018 on Thursday, 24 January 2019.
Malcolm Pye, Chief Executive Officer, Mark Plampin, Chief Financial Officer, and Alex Raeber, the recently appointed Chief Scientific Officer, will host a presentation for analysts on that day at 9.30am at the offices of Numis Securities, London Stock Exchange Building, 10 Paternoster Square, London, EC4M 7LT. To register your interest, please contact benchmark@mhpc.com.
Please note the change of venue to that stated in our previous announcement dated 7(th) November 2018.
Enquiries
Benchmark Holdings plc Tel: 020 7920 3150 Malcolm Pye, CEO Ivonne Cantu, Investor Relations Director Rachel Aninakwah, Communications Numis Tel: 020 7260 1000 Michael Meade / Freddie Barnfield (NOMAD) James Black (Corporate Broking) MHP Katie Hunt / Reg Hoare /Alistair Tel: 020 3128 8742 de Kare-Silver benchmark@mhpc.com
Notes to Editors:
Benchmark's mission is to drive sustainability in food production.
We are a leading provider of aquaculture solutions in genetics, health and specialist nutrition. Our focus is on developing innovative products that help fish and shrimp producers improve their sustainability and profitability by improving yield, quality, health and welfare. Our main products are salmon eggs with superior genetic traits, specialist nutrition products for shrimp and fish, and health treatments including a sea lice treatment for salmon. We serve all the major aquaculture markets around the world and have leading market positions. Benchmark operates in 27 countries, employs 1,066 people and reported revenues of GBP140m in 2017.
For further information on Benchmark please visit www.benchmarkplc.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
NORDFLFFKFFBBBV
(END) Dow Jones Newswires
January 14, 2019 02:00 ET (07:00 GMT)
1 Year Benchmark Chart |
1 Month Benchmark Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions